Navigation Links
NASH diagnosis set to improve with non-invasive tool

  • A Chinese study presented at the International Liver CongressTM 2013 has demonstrated the accuracy of a non-invasive test for non-alcoholic steatohepatitis (NASH) diagnosis.

  • Non Alcoholic Fatty Liver disease (NAFLD) comprises two groups of patients; one group with simple steatosis which is relatively benign and one group with NASH which may progress to cirrhosis and hepatocellular carcinoma. Up to now the only means of distinguishing the two was to perform a liver biopsy. Phosphorus magnetic resonance spectroscopy (31P-MRS), which allows non-invasive in vivo assessment of hepatocellular metabolism, was proven to show potential to distinguish the type of NAFLD.

  • The accuracy of the imaging technique could improve clinical procedures and enhance patient experience compared to the discomfort and risk of undergoing the 'gold standard' test (liver biopsy) currently used for diagnosing NAFLD. These results will now need to be prospectively confirmed in independent cohorts.

  • NASH is a more advanced form of NAFLD and its incidence and prevalence is rising. Although CT and ultrasound scans are potential diagnostic tools for NAFLD, currently only liver biopsy can confirm whether the simpler NAFLD is present or whether the more serious NASH has developed.

  • Using 31PMRS, the liver metabolite changes from 132 patients with biopsy-proven NAFLD were obtained and the diagnostic performance of 31P-MRS for NASH was determined.

  • 31P-MRS shows distinct alterations in ATP and PDE levels which are concordant with putative mechanisms in the progression of NAFLD. 31P-MRS shows fair diagnostic accuracy for NAFLD compared with liver biopsy, and using certain thresholds can be considered a reliable diagnostic tool for NASH.


Contact: Dimple Natali
European Association for the Study of the Liver

Page: 1

Related biology news :

1. Hand-held device cheaply, quickly diagnosis malaria
2. In autism, age at diagnosis depends on specific symptoms
3. European Guidance for the diagnosis & management of osteoporosis in postmenopausal women
4. Rapid, point-of-care tests for syphilis: The future of diagnosis
5. A genetic device performs DNA diagnosis
6. MicroRNAs present exciting opportunities for cancer therapy and diagnosis
7. An international competition reaffirms the potential of bioinformatics in the diagnosis of disease
8. Detection, analysis of cell dust may allow diagnosis, monitoring of brain cancer
9. Privately owned genetic databases may hinder diagnosis and bar the way to the arrival of personalized medicine
10. Plants provide accurate low-cost alternative for diagnosis of West Nile Virus
11. Obesity is major contributor to heart disease, impediment to diagnosis and treatment
Post Your Comments:
(Date:9/30/2015)... 30, 2015  The global glucose monitoring device and diabetes ... says a new report on the industry from Kalorama Information. Sales ... the market, followed by continuous glucose monitoring and sensor segment, ... market for these products in its latest report, The ... , ...
(Date:9/29/2015)... , Sept. 29, 2015  iDAvatars is excited to ... introduce its product to market. The official announcement was recently ... Economy event in San Francisco , ... platform powered by IBM Watson. "It is both ... first 100 companies to bring to market the cognitive power ...
(Date:9/28/2015)... 28, 2015  The monitoring of vital signs, ... temperature, is an essential component of patient assessment. ... deterioration in a patient,s condition. However, in general ... typically taken during routine observation rounds only once ... deteriorates between these observation rounds, the warning signs ...
Breaking Biology News(10 mins):
(Date:10/12/2015)...  Rebiotix Inc. today announced that U.S. Food ... Microbiota Restoration Therapy (MRT) RBX2660 as a Breakthrough ... difficile (C diff) infection, a challenging to ... in the U.S. annually. 1 Rebiotix is ... to revolutionize the treatment of debilitating GI diseases ...
(Date:10/12/2015)... 12, 2015  Patara Pharma, a clinical-stage biotechnology ... diseases and conditions, today announced the closing of ... Concurrent with the close of its sale of ... and Security Agreement with Silicon Valley Bank whereby ... Patara will use the funds from the financing ...
(Date:10/12/2015)... ... October 12, 2015 , ... Dr. Carl Peck, MD, Chairman ... firm as a Premier Expert consultant. NDA Partners Premier Experts are top ... to the company's clients. Premier Experts collaborate to design and implement critical ...
(Date:10/10/2015)... 10 octobre 2015 Le 8 octobre, l,honorable Doris ... Registre du Congrès sa déclaration de soutien à ... autour du plasma (IPAW), qui se tiendra du ... Plasma Protein Therapeutics Association (PPTA) et ... , Sensibiliser l,opinion publique mondiale autour du ...
Breaking Biology Technology: